Neurocrine Biosciences NBIX
NASDAQ NBIX
$142.70 -0.59 (-0.41%)
At close: Oct 23, 2026 · 4:00 PM EDT

Neurocrine Biosciences (NBIX) Sale and Maturity of Investments (2010 - 2026)

Updated

Analysis

Neurocrine Biosciences (NBIX) Sale and Maturity of Investments (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Neurocrine Biosciences 14.50 Bn 10.20 Bn 935.80 Mn 2.27 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.27 Bn
Mar 31, 2026 259.20 Mn
Dec 31, 2025 267.70 Mn
Sep 30, 2025 225.00 Mn
Jun 30, 2025 298.60 Mn
Mar 31, 2025 298.10 Mn
Dec 31, 2024 250.80 Mn
Sep 30, 2024 265.30 Mn
Jun 30, 2024 175.10 Mn
Mar 31, 2024 276.30 Mn
Dec 31, 2023 290.80 Mn
Sep 30, 2023 273.00 Mn
Jun 30, 2023 204.70 Mn
Mar 31, 2023 203.90 Mn
Dec 31, 2022 162.20 Mn
Sep 30, 2022 71.20 Mn
Jun 30, 2022 101.10 Mn
Mar 31, 2022 176.50 Mn
Dec 31, 2021 174.00 Mn
Sep 30, 2021 159.70 Mn
API Access

Neurocrine Biosciences Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=NBIX&period=max&api_key=YOUR_API_KEY